Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,704 public trials 1,045 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

NCT00428220

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +62 more
Locations
  • Emory University, Winship Cancer Institute Atlanta, Georgia, United States
  • Investigational Drug Service Atlanta, Georgia, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • Loyola University Medical Center Maywood, Illinois, United States
View all 113 locations
View Trial Details
Completed

Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer

NCT00065182

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
View all 85 locations
View Trial Details
Completed

Oncoxin® and Quality of Life in Cancer Patients

NCT03550482

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • Kazakh Research Institute of Oncology and Radiology Almaty, Kazakhstan
  • State Municipal Enterprise on the Right of Economic Management "Almaty Oncology Center" of Almaty Healthcare Administration Almaty, Kazakhstan
  • State-funded Institution of Khanty-Mansiysk Regional Clinical Hospital Ugra, Tyumen Oblast, Russia
  • Medical Center "EVIMED" LLC Chelyabinsk, Russia
View Trial Details
Completed

Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

NCT00234052

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • Rush Cancer Institute at Rush University Medical Center Chicago, Illinois, United States
  • Evanston Northwestern Healthcare - Evanston Hospital Evanston, Illinois, United States
  • Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey, Illinois, United States
View Trial Details
Completed

Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer

NCT02309177

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +18 more
Locations
  • UC Davis Cancer Center Sacramento, California, United States
  • University of California Los Angeles Santa Monica, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • H. Lee Moffitt Cancer Center and Research Institute University of South Florida Tampa, Florida, United States
View all 15 locations
View Trial Details

Related conditions